Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Annotation-free prediction of immunotherapy response in melanoma using single-cell transcriptomic data.
PMID 41758825 · PMC12948085 · PloS one · 2026 · 8 claims · 6 setups
AI-based predictive models built on unannotated scRNA-seq data (cell-by-gene expression matrices) can classify melanoma patients as ICI responders vs. non-responders
-
Full-text index only
Fibroblast-associated CTHRC1 as a key indicator of recurrence risk in prostate cancer.
PMID 41832493 · PMC13101373 · World journal of surgical oncology · 2026 · 7 claims · 8 setups
Pathological T stage, N stage, Gleason score, and TP53 mutation are associated with higher PRAD recurrence risk
-
Full-text index only
BCG-trained macrophages promote pan-anti-tumor activity through epigenetic rewiring of NOX2-ROS axis.
PMID 42032669 · PMC13261971 · Journal of experimental & clinical cancer research : CR · 2026 · 7 claims · 8 setups
BCG training induces pan-anti-tumor activity across multiple mouse tumor models, mediated predominantly by tumor-associated macrophages (TAMs)
-
Full-text index only
Single-cell mapping of cholesterol metabolism reveals FDPS as a therapeutic vulnerability in hepatocellular carcinoma.
PMID 41706364 · PMC12916967 · Cellular oncology (Dordrecht, Netherlands) · 2026 · 7 claims · 8 setups
Cholesterol metabolic activity is markedly elevated in HCC tumors and in immune checkpoint blockade (ICB) non-responders, with pronounced intratumoral heterogeneity across malignant cell subpopulations
-
Full-text index only
ZFP148 is a transcriptional repressor of cytolytic effector CD8(+) T cell differentiation.
PMID 41896465 · PMC13043298 · Nature immunology · 2026 · 8 claims · 8 setups
ZFP148 is enriched in CD8+ T progenitor (T PRO) cells and its expression declines during differentiation into effector (T EFF) and exhausted (T EX) cells